IP Library › Assignment 043447/0805
Patent Assignment
Reel/Frame 043447/0805

Assignment of Assignor's Interest

Recorded: 2017-08-30 Pages: 12
Assignors
LOTUS TISSUE REPAIR, INC.
Executed: 2017-07-21
Assignee
PHOENIX TISSUE REPAIR, INC.
P.O. BOX 370, ANDOVER, MASSACHUSETTS, 01810
Covered Properties (21)
Recombinant C7 and Methods of Use
Collagen 7 Compositions and Methods of Using the Same
Methods of Purifying Collagen 7
Inhibition of Telopeptide Lysyl Hydroxylase Activity or Production as Anti-Fibrotic Therapy
Patent: 6,733,988 →
Application: 09/450,209 →
Modification of Collagenous Materials and Medical Treatment, Diagnosis and Monitoring of Fibrotic Conditions
Patent: 7,045,600 →
Application: 10/184,372 →
Publication: US 2003/0219852
Modification of collagenous materials and medical treatment, diagnosis and monitoring of fibrotic conditions
Application: 11/247,659 →
Publication: US 2006/0141568
Method for Preparing Modified Collagen Outside a Host Cell
Patent: 7,932,053 →
Application: 11/547,822 →
Publication: US 2008/0086782
Modification of Collagenous Materials and Medical Treatment, Diagnosis and Monitoring of Fibrotic Conditions
Application: 12/556,409 →
Publication: US 2010/0035271
Recombinant C7 and Methods of Use
Application: 13/946,847 →
Publication: US 2014/0031295
Collagen 7 and Related Methods
Patent: 9,676,837 →
Application: 14/236,403 →
Publication: US 2015/0011733
Collagen Iv Binding Assay for the Detection of Collagen Vii
Patent: 9,733,263 →
Application: 14/440,958 →
Publication: US 2016/0011219
Administration of Recombinant Collagen 7 for the Treatment of Age Related Disorders
Application: 14/655,251 →
Publication: US 2015/0343026
Collagen 7 and Related Methods
Application: 15/596,447 →
Publication: US 2018/0002401
Collagen 7 and Related Methods
Application: 61/514,796 →
Recombinant C7 and Methods of Use
Application: 61/673,657 →
Collagen Iv Binding Assay for the Detection of Collagen Vii
Application: 61/723,372 →
Administration of Recombinant Collagen 7 for the Treatment of Age Related Disorders
Application: 61/746,421 →
Collagen 7 Compositions and Methods of Using the Same
Application: 62/278,816 →
Collagen 7 Compositions and Methods of Using the Same
Application: 62/293,209 →
Methods of Purifying Collagen 7
Application: 62/309,030 →
Collagen 7 compositions and methods of using the same
Application: 62/387,241 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 24, 2000
From: TE KOPPELE, JOHANNES MARIA; BANK, RUUD ANTONIUS
To: NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO
Reel/Frame 010645/0921 →
Assignment of Assignor's Interest Oct 15, 2002
From: BANK, RUDOLF ANTONIUS; VAN DER SLOT, ANNEMARIE JOZEFIEN; KOPPELE, JOHANNES MARIA TE
To: NEDERLANDSE ORGANISATIE VOOR TOEGEPASTNATUUR- WETENSCHAPPELIJK ONDERZOEK TNO
Reel/Frame 013383/0775 →
Assignment of Assignor's Interest Mar 23, 2007
From: BANK, RUDOLF ANTONIUS; ZUURMOND, ANNE-MARIE; JORE, JOHANNES PETRUS MARIA; VAN DEN HONDEL, CORNELIS ANTONIUS MARIA JACOBUS JOHANNES
To: NEDERLANDSE ORGANISATIE VOOR TOEGEPASTNATUURWETENSCHAPPELIJK ONDERZOEK TNO
Reel/Frame 019060/0070 →
Assignment of Assignor's Interest Aug 3, 2012
From: VISWANATHAN, MALINI; DE SOUZA, MARK
To: LOTUS TISSUE REPAIR INC.
Reel/Frame 028715/0139 →
Assignment of Assignor's Interest Dec 14, 2012
From: MAGIL, SHEILA G.
To: LOTUS TISSUE REPAIR INC.
Reel/Frame 029468/0602 →
Assignment of Assignor's Interest Jan 2, 2013
From: GILCHREST, BARBARA
To: LOTUS TISSUE REPAIR INC.
Reel/Frame 029561/0130 →
Assignment of Assignor's Interest Jan 24, 2013
From: CHEN, MEI; WOODLEY, DAVID
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 029690/0339 →
Assignment of Assignor's Interest Jun 5, 2014
From: DESOUZA, MARK
To: LOTUS TISSUE REPAIR, INC.
Reel/Frame 033097/0050 →
Assignment of Assignor's Interest Jun 5, 2014
From: CHEN, MEI; WOODLEY, DAVID
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 033042/0148 →
Assignment of Assignor's Interest Sep 11, 2014
From: VISWANATHAN, MALINI; DE SOUZA, MARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 033722/0643 →
Assignment of Assignor's Interest Sep 18, 2014
From: NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJKONDERZOEK TNO
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 033766/0117 →
Confirmatory License Mar 24, 2015
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035263/0054 →
Assignment of Assignor's Interest Nov 25, 2016
From: QUINONES-GARCIA, IGOR; SIMEONE, BENJAMIN; YANG, TING; NICHOLS, DAVID
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 040681/0615 →
Assignment of Assignor's Interest Dec 20, 2016
From: LILLIE, RAYMOND
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 040693/0643 →
Assignment of Assignor's Interest Jan 3, 2017
From: GUEY, LIN; QUINONES-GARCIA, IGOR
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 040826/0662 →
Assignment of Assignor's Interest Jan 3, 2017
From: GUEY, LIN; QUINONES-GARCIA, IGOR
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 040826/0731 →
Assignment of Assignor's Interest Jan 10, 2017
From: LOWE, KRIS; NGUYEN, VINH; HE, BING; BANDEKAR, AMEY
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 040936/0621 →
Assignment of Assignor's Interest Jan 18, 2017
From: QUINONES-GARCIA, IGOR; GUEY, LIN; LOWE, KRIS; NGUYEN, VINH
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 041004/0661 →
Assignment of Assignor's Interest May 18, 2017
From: VISWANATHAN, MALINI; DE SOUZA, MARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 042500/0256 →
Assignment of Assignor's Interest Feb 12, 2018
From: QUINONES-GARCIA, IGOR; SIMEONE, BENJAMIN; NICHOLS, DAVID; YANG, TING
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 044900/0380 →
Assignment of Assignor's Interest Feb 12, 2018
From: DE SOUZA, MARK; VISWANATHAN, MALINI
To: LOTUS TISSUE REPAIR, INC.
Reel/Frame 044898/0377 →
Security Interest Nov 17, 2021
From: BRIDGEBIO PHARMA, INC.; ORIGIN BIOSCIENCES, INC.; EIDOS THERAPEUTICS, INC.; QED THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 058144/0302 →
Security Interest Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Release of Security Interest Jan 18, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS SUCCESSOR TO U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: BRIDGEBIO PHARMA, INC.; ORIGIN BIOSCIENCES, INC.; EIDOS THERAPEUTICS, INC.; QED THERAPEUTICS, INC.
Reel/Frame 066167/0462 →
Security Interest Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →